SCHEMBL7340811

SCHEMBL7340811

O=C(N[C@H]1CCC[C@@H]1O)OCc1cccnc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.52
HDAC8 Q9BY41 1/20 0.49
CHRM1 P11229 2/20 0.48
ALDH1A1 P00352 2/20 0.47
MEN1 O00255 1/20 0.47
LMNA P02545 1/20 0.47
MAPT P10636 1/20 0.47
HTT P42858 1/20 0.47
KMT2A Q03164 1/20 0.47
CYP17A1 P05093 1/20 0.47
CYP19A1 P11511 1/20 0.47
HDAC1 Q13547 1/20 0.46
NAAA Q02083 1/20 0.46
NAMPT P43490 1/20 0.46
FAAH O00519 1/20 0.43
CYP3A4 P08684 2/20 0.43
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
GRIN2B Q13224 1/20 0.42
CASP3 P42574 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7327467 0.98 CNR1 (0.55) CNR1HDAC8CHRM1ALDH1A1MEN1
SCHEMBL31064941 0.84 ALDH1A1 (0.57) ALDH1A1MEN1KMT2ACASP3GAA
SCHEMBL2848375 0.84 ALDH1A1 (0.57) ALDH1A1MEN1KMT2ACASP3GAA
SCHEMBL5897658 0.84 ALDH1A1 (0.57) ALDH1A1MEN1KMT2ACASP3GAA
SCHEMBL5896895 0.84 ALDH1A1 (0.57) ALDH1A1MEN1KMT2ACASP3GAA
SCHEMBL5896898 0.84 ALDH1A1 (0.57) ALDH1A1MEN1KMT2ACASP3GAA
SCHEMBL5897664 0.84 ALDH1A1 (0.57) ALDH1A1MEN1KMT2ACASP3GAA
SCHEMBL5749471 0.82 EPHX1 (0.58) ALDH1A1MEN1KMT2ACASP3GAA
SCHEMBL13326281 0.82 EPHX1 (0.58) ALDH1A1MEN1KMT2ACASP3GAA
SCHEMBL13917140 0.82 EPHX1 (0.58) ALDH1A1MEN1KMT2ACASP3GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0997459-A1 Intermediates for preparing retroviral protease inhibiting compounds Abbott Laboratories (US) 2000-05-03 EP disclosed
US-5990135-A FOR TREATING A RETROVIRAL INFECTION SUCH AS HIV INFECTION; FOR EXAMPLE 5S-N-((2-PYRIDINYL)METHOXYCARBONYL)VALINYLAMINO-2-((N-3 -PYRIDINYL)METHOXYCARBONYL)AMINO-4S-HYDROXY-1,6-DIPHENYL-2-AZAHEXANE AND OTHER COMPOUNDS OF GIVEN FORMULA ABBOTT LABORATORIES (US) 1999-11-23 US disclosed
US-5837873-A PROTECTED OXYDIAMINES ABBOTT LABORATORIES (US) 1998-11-17 US disclosed
US-5648497-A Retroviral protease inhibiting compounds ABBOTT LABORAOTRIES (US) 1997-07-15 US disclosed
US-5631376-A PEPTIDE DERIVATIVES FOR TREATMENT OF AIDS ABBOTT LABORATORIES (US) 1997-05-20 US disclosed
US-5621109-A OXAZOLE/THIAZOLE DERIVATIVES OF HYDROXYMETHYL HYDRAZONES; SIDE EFFECT REDUCTION ABBOTT LABORATORIES (US) 1997-04-15 US disclosed
US-5616714-A PYRIDYL, THIAZOLYL-SUBSTITUTED AMINO ACID DERIVATIVES ABBOTT LABORATORIES (US) 1997-04-01 US disclosed
US-5597926-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-01-28 US disclosed
US-5554783-A (2R, 3R, 4S, 5S)-3-ACETOXY-2,5-BIS/BENZYLOXYCARBONYLAMINO/ -4-BROMO-1,5-DIPHENYLHEXANE ABBOTT LABORATORIES (US) 1996-09-10 US disclosed
US-5541334-A TREATING HIV ABBOTT LABORATORIES (US) 1996-07-30 US disclosed
US-5461067-A For HIV infections ABBOTT LABORATORIES (US) 1995-10-24 US disclosed
US-5354866-A Treating HIV infections ABBOTT LABORATORIES (US) 1994-10-11 US disclosed
EP-0486948-A2 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1992-05-27 EP disclosed